Wednesday, July 19, 2017 3:30:57 PM
You people can talk whatever you want about "bottoms", "double-dips", etc. but coming from Pharma industry & knowing how heaviliy it is regulated (public safety) I tell you it takes time, and with new JOINT ventures between CNBX (this company - Cannabics Pharmaceuticals), latest being exclusive agreemnt of CNBX w/ Germany's SIMFO GmbHa (a world leader in cancer diagnostics & liquid biopsies located in Germany) a week ago (12 July 2017), as just one example, I am tired of seeing "doom & gloom" posts here.
This stock will go up to $4-4.70/share range before October 2017 OR SOONER. And you sellers will LOSE.
meanwhile, yesterday I bought 7,500 shares more of it, on top of my existing 12,000 (and might add more, this week/early next weeks, thanks for bringing PPS down to where I can buy huge volume of it!).
Recent CNBX News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 09:27:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/12/2024 03:13:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/14/2023 02:28:11 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM